Breaking News

Bionova Scientific to Open New Plasmid DNA GMP Facility in TX

Facility to produce critical starting material for cell and gene therapy, DNA/RNA-based, and recombinant protein therapeutics.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Bionova Scientific, an Asahi Kasei Group company and full-service biologics CDMO, plans to expand into plasmid DNA (pDNA) production. The centerpiece of the project is a new development and manufacturing facility in The Woodlands, Texas (near Houston). When the new facility begins operation (planned for Q1/2025), Bionova Scientific will offer pDNA development services and production of research grade and high quality pDNA. GMP manufacturing is planned for later in 2025.   The expansion is part...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters